The Discounted Cash Flow (DCF) valuation of AtriCure Inc (ATRC) is (19.31) USD. With the latest stock price at 34.55 USD, the upside of AtriCure Inc based on DCF is -155.9%.
Based on the latest price of 34.55 USD and our DCF valuation, AtriCure Inc (ATRC) is a sell. selling AtriCure stocks now will result in a potential gain of 155.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 10.2% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (53.71) - (11.93) | (19.31) |
| Upside | -255.4% - -134.5% | -155.9% |